Skip to content

Pediatrix Medical Group MD Cash Provided by (Used in) Investing Activity, Including Discontinued Operation

Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies

ARD
Ardent Health PartnersARDT
-$27.9M-20.7%
HCA Healthcare logo
HCA HealthcareHCA
-$1.28B-24.2%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.99B+42.9%
Enterprise value$2.41B+22.3%
P/E11.4×
P/S+0.3×

Profitability

See full
Operating margin11.3%
Net margin9%
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's cash provided by (used in) investing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's cash provided by (used in) investing activity, including discontinued operation?
Pediatrix Medical Group (MD) reported cash provided by (used in) investing activity, including discontinued operation of -$11.98M in Q1 2026.
How has Pediatrix Medical Group's cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
Pediatrix Medical Group's cash provided by (used in) investing activity, including discontinued operation decreased by 60.5% year-over-year, from -$7.46M to -$11.98M.
What is the long-term trend for Pediatrix Medical Group's cash provided by (used in) investing activity, including discontinued operation?
Over 3 years (2021 to 2024), Pediatrix Medical Group's cash provided by (used in) investing activity, including discontinued operation has grown at a -12.6% compound annual growth rate (CAGR), from -$53.07M to -$35.41M.
What does cash provided by (used in) investing activity, including discontinued operation mean?
The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.